LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 101 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q1 2017. The put-call ratio across all filers is 2.05 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $488,000 | -0.2% | 16,392 | 0.0% | 0.06% | +14.6% |
Q1 2017 | $489,000 | -42.6% | 16,392 | -69.2% | 0.05% | -57.5% |
Q2 2016 | $852,000 | -26.7% | 53,254 | -4.2% | 0.11% | -19.9% |
Q1 2016 | $1,163,000 | -3.2% | 55,600 | +25.0% | 0.14% | -6.0% |
Q4 2015 | $1,201,000 | +262.8% | 44,463 | +273.6% | 0.15% | +233.3% |
Q3 2015 | $331,000 | – | 11,900 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG KEVIN C | 240,000 | $1,018,000 | 94.79% |
TANG CAPITAL MANAGEMENT LLC | 9,405,490 | $39,879,000 | 11.22% |
RTW INVESTMENTS, LP | 2,327,903 | $9,870,000 | 0.15% |
Boxer Capital, LLC | 890,700 | $3,777,000 | 0.13% |
FIRST MIDWEST BANK TRUST DIVISION | 89,341 | $379,000 | 0.05% |
WealthTrust Axiom LLC | 30,400 | $128,000 | 0.04% |
PREMIER ASSET MANAGEMENT LLC | 51,305 | $217,000 | 0.04% |
OCCUDO QUANTITATIVE STRATEGIES LP | 18,113 | $77,000 | 0.02% |
HOLLENCREST CAPITAL MANAGEMENT | 39,000 | $165,000 | 0.02% |
Inscription Capital, LLC | 10,000 | $42,000 | 0.01% |